#Parenting

A leader in the field of regenerative medicine.

ACT receives UK MHRA clearance for hESC-derived RPE cell trial for Stargardt’s Macular Dystrophy Advanced Cellular Technology, Inc comprar priligy online . ;, a leader in the field of regenerative medicine, today that it offers received clearance from the U announced.K. Medicines and Healthcare products Regulatory Company to begin treating patients within a Phase 1/2 scientific trial for Stargardt’s Macular Dystrophy using retinal pigment epithelium derived from human being embryonic stem cells . ACT received similar approval from the Gene Therapy Advisory Committee , which includes responsibility for the ethical oversight of proposals to conduct medical trials involving gene or stem cell therapies in the U.K.